Protective effects of astaxanthin on particulate matter 2.5‑induced senescence in HaCaT keratinocytes via maintenance of redox homeostasis
- Authors:
- Published online on: May 8, 2024 https://doi.org/10.3892/etm.2024.12563
- Article Number: 275
-
Copyright: © Zhen et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
Metrics: Total
Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Abstract
Particulate matter 2.5 (PM2.5) imposes a heavy burden on the skin and respiratory system of human beings, causing side effects such as aging, inflammation and cancer. Astaxanthin (ATX) is a well‑known antioxidant widely used for its anti‑inflammatory and anti‑aging properties. However, few studies have investigated the protective effects of ATX against PM2.5‑induced senescence in HaCaT cells. In the present study, the levels of reactive oxygen species (ROS) and antioxidant enzymes were measured after treatment with PM2.5. The results revealed that PM2.5 generated excessive ROS and reduced the translocation of nuclear factor erythroid 2‑related factor 2 (NRF2), subsequently reducing the expression of antioxidant enzymes. However, pretreatment with ATX reversed the ROS levels as well as the expression of antioxidant enzymes. In addition, ATX protected cells from PM2.5‑induced DNA damage and rescued PM2.5‑induced cell cycle arrest. The levels of senescence‑associated phenotype markers, such as interleukin‑1β, matrix metalloproteinases, and β‑galactosidase, were increased by exposure to PM2.5, however these effects were reversed by ATX. After interfering with NRF2 mRNA expression and exposing cells to PM2.5, the levels of ROS and β‑galactosidase were higher compared with siControl RNA cells exposed to PM2.5. However, ATX inhibited ROS and β‑galactosidase levels in both the siControl RNA and the siNRF2 RNA groups. Thus, ATX protects HaCaT keratinocytes from PM2.5‑induced senescence by partially inhibiting excessive ROS generation via the NRF2 signaling pathway.